DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,607,132 | -70.9% | 10,508 | -71.8% | 0.07% | -64.7% |
| Q2 2023 | $8,949,520 | +261.0% | 37,279 | +279.4% | 0.20% | +204.5% |
| Q1 2023 | $2,478,959 | -6.5% | 9,826 | -1.5% | 0.07% | -10.8% |
| Q4 2022 | $2,651,066 | +5.6% | 9,980 | +2.7% | 0.07% | -2.6% |
| Q3 2022 | $2,511,000 | +19.1% | 9,717 | +16.9% | 0.08% | -14.6% |
| Q2 2022 | $2,109,000 | +2.5% | 8,310 | +18.5% | 0.09% | +32.8% |
| Q1 2022 | $2,058,000 | +2.7% | 7,014 | +15.3% | 0.07% | +15.5% |
| Q4 2021 | $2,003,000 | +17.1% | 6,085 | +5.9% | 0.06% | +7.4% |
| Q3 2021 | $1,711,000 | +32.6% | 5,745 | +16.6% | 0.05% | +28.6% |
| Q2 2021 | $1,290,000 | +14.1% | 4,925 | -2.1% | 0.04% | +5.0% |
| Q1 2021 | $1,131,000 | +35.9% | 5,031 | +34.4% | 0.04% | -11.1% |
| Q4 2020 | $832,000 | +33.5% | 3,742 | +25.6% | 0.04% | +36.4% |
| Q3 2020 | $623,000 | +46.9% | 2,979 | +24.6% | 0.03% | +17.9% |
| Q2 2020 | $424,000 | +5.0% | 2,390 | -18.0% | 0.03% | -17.6% |
| Q1 2020 | $404,000 | +39.8% | 2,914 | +55.1% | 0.03% | +36.0% |
| Q4 2019 | $289,000 | -39.7% | 1,879 | -43.2% | 0.02% | -46.8% |
| Q3 2019 | $479,000 | 0.0% | 3,311 | -0.9% | 0.05% | -9.6% |
| Q2 2019 | $479,000 | +17.4% | 3,340 | +8.3% | 0.05% | +2.0% |
| Q1 2019 | $408,000 | +41.7% | 3,085 | +10.8% | 0.05% | +24.4% |
| Q4 2018 | $288,000 | -2.0% | 2,785 | +3.3% | 0.04% | +17.1% |
| Q3 2018 | $294,000 | +12.6% | 2,697 | +2.1% | 0.04% | +2.9% |
| Q2 2018 | $261,000 | -32.0% | 2,641 | -32.5% | 0.03% | -37.0% |
| Q1 2018 | $384,000 | +8.2% | 3,910 | +2.4% | 0.05% | +12.5% |
| Q4 2017 | $355,000 | +12.0% | 3,820 | +3.6% | 0.05% | -9.4% |
| Q3 2017 | $317,000 | -0.3% | 3,687 | -2.1% | 0.05% | -8.6% |
| Q2 2017 | $318,000 | -0.9% | 3,767 | +0.4% | 0.06% | -9.4% |
| Q1 2017 | $321,000 | +46.6% | 3,753 | +33.7% | 0.06% | +42.2% |
| Q4 2016 | $219,000 | +4.8% | 2,806 | +5.5% | 0.04% | +9.8% |
| Q3 2016 | $209,000 | -20.5% | 2,659 | +2.3% | 0.04% | -22.6% |
| Q2 2016 | $263,000 | +19.0% | 2,600 | +11.3% | 0.05% | +3.9% |
| Q1 2016 | $221,000 | -45.4% | 2,337 | -50.9% | 0.05% | -48.5% |
| Q1 2015 | $405,000 | -91.1% | 4,764 | -24.8% | 0.10% | +2.1% |
| Q4 2014 | $4,549,000 | +1153.2% | 6,334 | +32.8% | 0.10% | +76.4% |
| Q3 2014 | $363,000 | -99.9% | 4,771 | -47.2% | 0.06% | -27.6% |
| Q2 2014 | $323,048,000 | +168154.2% | 9,043 | +253.1% | 0.08% | +31.0% |
| Q1 2014 | $192,000 | +15.0% | 2,561 | +18.2% | 0.06% | +9.4% |
| Q4 2013 | $167,000 | +11.3% | 2,166 | 0.0% | 0.05% | +3.9% |
| Q3 2013 | $150,000 | +11.9% | 2,166 | +2.4% | 0.05% | +13.3% |
| Q2 2013 | $134,000 | – | 2,116 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |